This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The $2,168.80 firm fixed-price delivery order contract covers the supply of Olumiant 2 mg tablets, a medication used to treat certain autoimmune conditions. The contract has an ultimate completion date of October 16, 2024.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is likely part of that broader IDC mechanism, enabling efficient government procurement of essential medications. The contract does not have a set-aside designation, indicating open competition.
Generated 2/27/25, 1:23 PM